At the current share price it is a no brainer where I put my money. The upside to this company is huge and as Graham Kelly has repeatedly pointed out, the preclinical and clinical data to date has shown that Veyonda more than likely will work. Once proven, NOX could be the most lucrative investment one can ever make.
